PBIO Financials Monday, July 14, 2014 11:40:30 PM
Pressure BioSciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,503 1,238 988 1,340
Cost of Revenue 568 416 343 377
Gross Profit 935 822 645 964
Operating Expenses
Research and Development 1,035 966 969 1,233
Sales, General and Admin. 3,227 3,320 2,966 3,130
Non-Recurring Items - - - -
Other - - - -
Operating Income (3,327) (3,464) (3,290) (3,399)
Income From Continuing Operations
Add'l Income/Expense Items (417) 145 430 244
Earnings Before Interest and Tax (3,745) (3,319) (2,996) (3,152)
Interest Expense 340 133 - -
Earnings Before Tax (4,084) (3,452) (2,996) (3,152)
Income Tax - (2) - (24)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,084) (3,450) (2,996) (3,128)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,084) (3,450) (2,996) (3,128)
Preferred Stock and Other Adjustments (1,163) (950) (2,111) (503)
Net Income Applicable to Common Shareholders (5,247) (4,400) (5,108) (3,631)